Alpha Cognition (ACOG) Gross Margin (2025 - 2026)

Alpha Cognition (ACOG) posted quarterly Gross Margin of 93.58% for Q4 2025, down 0.73% quarter-over-quarter from 94.27% in Q3 2025.

Alpha Cognition (ACOG) Gross Margin (2025 - 2026) Analysis & Trends

Alpha Cognition's Gross Margin history runs 1 years deep, the most recent figure standing at 93.58% for Q4 2025.

In Q4 2025, Gross Margin changed N/A year-over-year to 93.58%; the TTM figure through Dec 2025 stood at 92.08% (changed N/A YoY), while the FY2025 annual figure was 95.36%, changed N/A from the prior year.
Gross Margin for Q4 2025 stood at 93.58%, down from 94.27% in the prior quarter.
The five-year high for Gross Margin was 99.09% in Q1 2025, with the low at 73.4% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Vertex Pharmaceuticals	139.29 Bn	131.44 Bn	2.84 Bn	85.33%
2	Regeneron Pharmaceuticals	86.31 Bn	78.32 Bn	3.93 Bn	91.59%
3	Argenx Se	64.95 Bn	59.77 Bn	1.37 Bn	90.43%
4	Moderna	59.49 Bn	54.36 Bn	52.00 Mn	35.86%
5	BeOne Medicines	42.02 Bn	36.92 Bn	1.53 Bn	89.76%
6	Alnylam Pharmaceuticals	30.79 Bn	27.48 Bn	992.69 Mn	76.90%
7	BioNTech SE	28.26 Bn	9.87 Bn	668.28 Mn	63.27%
8	Insmed	27.30 Bn	26.14 Bn	358.27 Mn	84.20%
9	Royalty Pharma	27.10 Bn	26.26 Bn	-	-
10	Alpha Cognition	216.00 Mn	174.56 Mn	5.70 Mn	93.58%

Download Data